The protective effect of smoking against COVID-19: A population-based study using instrumental variables

Zakharov, Nikita (2020): The protective effect of smoking against COVID-19: A population-based study using instrumental variables.

Abstract

A low prevalence of smokers among the confirmed patients with COVID-19 has been reported by multiple hospital-based studies, and this observation gave rise to a hypothesis that smoking has a protective effect against the novel coronavirus. We test this prediction in a population-based study across the US states and use an instrumental variable approach to address the endogeneity of smoking rates. We find that a higher prevalence of smoking has a significant negative effect on the spread and the severity of the COVID-19 pandemic across the US state: it decreases the per capita number of registered cases, the case fatality rate, and the excess mortality. The protective effect is more pronounced in subgroups of the population that are more likely to be smokers: men of all ages and females of the older cohort. Our findings are robust to the inclusion of a broad range of control variables, exclusion of outliers, and placebo tests. Despite the protective effect against the COVID-19, smoking remains detrimental for health in the long-term, and we show that states with a higher rate of smoking also have higher mortality in the year before the outbreak.

• Item Type: MPRA Paper
• Language: English
• Keywords: COVID-19, US states, smoking, cigarettes, case fatality rate, excess mortality
• Subjects: H - Public Economics > H7 - State and Local Government ; Intergovernmental Relations > H71 - State and Local Taxation, Subsidies, and Revenue; I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior; I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health; J - Labor and Demographic Economics > J1 - Demographic Economics > J11 - Demographic Trends, Macroeconomic Effects, and Forecasts

References

Bello, S., Menéndez, R., Antoni, T., Reyes, S., Zalacain, R., Capelastegui, A., Aspa, J., Borderías, L., Martin-Villasclaras, J. J., Alfageme, I., De Castro, F. R., Rello, J., Luis, M., & Ruiz-Manzano, J. (2014). Tobacco smoking increases the risk for death from pneumococcal pneumonia. Chest, 146(4), 1029-1037.

Brake, S. J., Barnsley, K. I., Lu, W., McAlinden, K. D., Eapen, M. S., & Sohal, S. S. (2020). Smoking upregulates angiotensin-converting enzyme-2 receptor: A potential adhesion site for Novel Coronavirus SARS-CoV-2. Journal of Clinical Medicine, 9(3), 1-7.

Burns, D. M., Lee, L., Shen, L. Z., Gilpin, E., Tolley, H. D., Vaughn, J., & Shanks, T. G. (1997). Cigarette smoking behavior in the United States. In: Burns, D.M., Garfinkel, L., and Samet, J. (Eds.) Changes in cigarette-related disease risks and their implication for prevention and control. Smoking and tobacco control monograph No. 8. Bethesda, MD: Cancer Control and Population Sciences, National Cancer Institute, US National Institutes of Health. 13-42.

Cai, Q., Chen, F., Wang, T., Luo, F., Liu, X., Wu, Q., He, Q., Wang, Z., Liu, Y., Liu, L., Chen, J. & Xu, L. (2020). Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care, forthcoming.

CDC. (2018). State Tobacco Activities Tracking and Evaluation (STATE) system. Centers for Disease Control and Prevention. Online: http://www.cdc.gov/statesystem.

Changeux, J. P., Amoura, Z., Rey, F., & Miyara, M. (2020). A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. Qeios PrePrint.

Charlton, A. (2004). Medicinal uses of tobacco in history. Journal of the Royal Society of Medicine, 97(6), 292-296.

Chow N, Fleming-Dutra K, Gierke R, Hall A (2020) Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States. February 12 - March 28, 2020. MMWR Weekly Report 69:382–386.

Department of Health and Human Services. (2001). Women and smoking: A report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2001.

Egorov, G., Enikolopov, R., Makarin, A., & Petrova, M. (2020). Divided we stay home: Social distancing and ethnic diversity. National Bureau of Economic Research, Working paper No. w27277.

Farsalinos, K., Barbouni, A., & Niaura, R. (2020a). Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: Could nicotine be a therapeutic option? Internal and Emergency Medicine, 1-8.

Farsalinos, K., Poulas, K., Polosa, R., Barbouni, A., Caponnetto, P., & Niaura, R. (2020c). Prevalence of current smoking and association with adverse outcome in hospitalized COVID-19 patients: A systematic review and meta-analysis. PrePrints 2020050113, May 5.

French, M. T., & Popovici, I. (2011). That instrument is lousy! In search of agreement when using instrumental variables estimation in substance use research. Health economics, 20(2), 127-146.

Garufi, G., Carbognin, L., Orlandi, A., Tortora, G., & Bria, E. (2020). Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence. European Journal of Internal Medicine, forthcoming.

Gonzalez-Rubio, J., Navarro-Lopez, C., Lopez-Najera, E., Lopez-Najera, A., Jiménez-Díaz, L., Navarro-López, J. D., & Nájera, A. (2020). What is happening with smokers and COVID-19? A systematic review and a meta-analysis. Preprints 2020040540, April 30.

Hefler, M., & Gartner, C. E. (2020). The tobacco industry in the time of COVID-19: Time to shut it down? Tobacco Control, 29, 245-246.

John, U., Hanke, M., Meyer, C., & Schumann, A. (2005). Gender and age differences among current smokers in a general population survey. BMC Public Health, 5(1), 57.

Kloc, M., Ghobrial, R. M., & Kubiak, J. Z. (2020). How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? Immunology Letters, 224, 28-29.

Kontis, V., Mathers, C. D., Bonita, R., Stevens, G. A., Rehm, J., Shield, K. D., Riley, L. M., Poznyak, V., Jabbour, S., Garg, R. M., Fouad, H., Beaglehole, R., Ezzati, M., & Hennis, A. (2015). Regional contributions of six preventable risk factors to achieving the 25× 25 non-communicable disease mortality reduction target: a modelling study. Lancet Global Health, 3(12), e746-e757.

Lawrence, H., Hunter, A., Murray, R., Lim, W. S., & McKeever, T. (2019). Cigarette smoking and the occurrence of influenza–Systematic review. Journal of Infection, 79(5), 401-406.

Manski, C. F., & Molinari, F. (2020). Estimating the COVID-19 infection rate: Anatomy of an inference problem. Journal of Econometrics, forthcoming.

Maryland Transportation Institute (2020). University of Maryland COVID-19 Impact Analysis Platform. University of Maryland, College Park, USA. https://data.covid.umd.edu.

Millett G.A., Jones A. T., Benkeser D., Baral S., Mercer L., Beyrer C., Honermann B., Lankiewicz E., Mena L., Crowley J. S., Sherwood J., & Sullivan P. (2020). Assessing differential impacts of COVID-19 on black communities. Annals of Epidemiology, forthcoming.

Miyara, M., Tubach, F., Pourcher, V., Morelot-Panzini, C., Pernet, J., & Haroche, J. (2020). Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19. Qeios PrePrint, April 20.

Mollalo, A., Vahedi, B., & Rivera, K. M. (2020). GIS-based spatial modeling of COVID-19 incidence rate in the continental United States. Science of The Total Environment, 138884.

Nam, C. B., & Rogers, R. G. (1998). Adult mortality differentials associated with cigarette smoking in the USA. Population Research and Policy Review, 17(3), 285-304.

Nishiura, H., Kobayashi, T., Miyama, T., Suzuki, A., Jung, S. M., Hayashi, K., Kinoshita, R., Yang, Y., Yuan, B., Akhmetzhanov, A. R., & Linton, N. M. (2020). Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). International Journal of Infectious Diseases.94, 154–155.

Petrilli, C. M., Jones, S. A., Yang, J., Rajagopalan, H., O’Donnell, L. F., Chernyak, Y., Tobin, K., Cerfolio, R. J., Francois, F., & Horwitz, L. I. (2020). Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. MedRxiv, April 11.

Polosa, R., & Caci, G. (2020). COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine. Internal and Emergency Medicine, forthcoming.

Shipan, C. R., & Volden, C. (2006). Bottom‐up federalism: The diffusion of anti-smoking policies from US cities to states. American Journal of Political Science, 50(4), 825-843.

Staiger, D., & Stock, J. (1997). Instrumental variables regression with weak instruments. Econometrica, 65(3), 557-586.

Waldron, I. (1991). Patterns and causes of gender differences in smoking. Social Science & Medicine, 32(9), 989-1005.

WHO (2020). Smoking and COVID-19. Scientific Brief. Online: WHO/2019-nCoV/Sci_Brief/Smoking/2020.1.

Zhang L, Ghader S, Pack M, Darzi A, Xiong C, Yang M, Sun Q, Kabiri A, Hu S. (2020). An interactive COVID-19 mobility impact and social distancing analysis platform. medRxiv 2020.